Determining the patterns of DNA sequence variation in the human genome is a useful first step toward identifying the genetic basis of a common disease. A haplotype map (HapMap), aimed at describing these variation patterns across the entire genome, has been recently developed by the International HapMap Consortium. In this article, we present a novel statistical model for directly characterizing specific sequence variants that are responsible for disease risk based on the haplotype structure provided by HapMap. Our model is developed in the maximum-likelihood context, implemented with the EM algorithm. We perform simulation studies to investigate the statistical properties of this disease-sequencing model. A worked example from a human obesity study with 155 patients was used to validate this model. In this example, we found that patients carrying a haplotype constituted by allele Gly16 at codon 16 and allele Gln27 at codon 27 genotyped within the ␤2AR candidate gene display significantly lower body mass index than patients carrying the other haplotypes. The implications and extensions of our model are discussed.
C
URRENT studies of genetic mapping have been detected with given markers cannot give any information about the sequence structure and organization of QTL. veloped to a point at which the quantitative variation of almost any complex trait can be dissected into its Second, the inference of the QTL positions using the nearby markers is sensitive to marker informativeness, underlying Mendelian factors on the basis of molecular linkage maps (Lander and Botstein 1989) or association marker density, and mapping population type. As a result of these, only a few QTL detected from markers have studies (Wu et al. 2002; Lou et al. 2003) . Such Mendelian factors, i.e., the so-called quantitative trait loci (QTL) , been successfully cloned (Frary et al. 2000) , despite a considerable number of QTL reported in the literature. are hypothesized regions with alleles triggering an effect on quantitative variation. A number of statistical meth-A more accurate and useful approach for the characterization of genetic variants contributing to quantitative ods have been developed to map QTL for various map- variation is to directly analyze DNA sequences associated ping population structures and different marker and with a particular disease. If a string of DNA sequence character types, each aimed at precisely identifying QTL is known to increase disease risk, this risk can be reduced that are close enough to markers for their positional by the alteration of this string of DNA sequence using a cloning using biotechnology approaches, such as chrospecialized drug. The control of this disease can be made mosome walks (Wu and Casella 2005) . These methods more efficient if all possible DNA sequences determinhave led to the detection of QTL contributing to coming its variation are identified in the entire genome. plex traits in a range of species from microorganisms
With the recent development of the human genome to plant and animal species to humans (Mackay 2001) .
project, massive amounts of DNA sequence data have The basic principle for QTL mapping is the cosegrebeen available across the human genome (Internagation of the alleles at a QTL with those at one or a set of tional HapMap Consortium 2003). In particular, sinknown polymorphic markers genotyped on a genome. If gle-nucleotide polymorphisms (SNPs), being the most a QTL is cosegregating with molecular markers, the gecommon type of variant in the DNA sequence, provide netic effects of QTL and their genomic positions can a powerful means for genotyping the whole genome. be estimated from the markers. This approach is robust This facilitates the complete identification of specific and powerful for the detection of major QTL and presequence variants responsible for complex diseases. A sents the most efficient way to utilize marker informalinear arrangement of alleles (i.e., nucleotides) at differtion when marker maps are sparse. However, this apent SNPs on a single chromosome, or part of a chromoproach is limited in two aspects. First, because the markers some, is called a haplotype. The cosegregation of SNP and QTL bracketed by them are located at different alleles on haplotypes leads to nonrandom association, genomic positions, the significant linkage of a QTL dei.e., linkage disequilibrium (LD) , between these alleles in the population. Empirical analyses of LD for SNPs have shown that nearby SNPs in the human genome tend to 1 tributed in block-like patterns, rather than displaying Our interest is to search for the haplotype diversity that can explain phenotypic variation in a complex disrandom-or even-spaced distribution as originally predicted (Patil et al. 2001; Dawson et al. 2002; Gabriel ease. The association between haplotype diversity and phenotypic variation has been detected in several studet al. 2002) . SNPs within haplotype blocks are much more strongly associated with each other than are those ies of drug responses ( Judson et al. 2000; Bader 2001 ). This allows us to assume that a particular haplotype is between different blocks. Haplotype diversity within each different from other haplotypes for a given disease. Beblock can be well explained by only a finite number cause haplotypes (comprising diplotypes) cannot be diof SNPs, called tag SNPs or representative SNPs. The rectly observed, the effects of different haplotypes on existence of these tag SNPs means that it is not necesthe phenotype need be postulated from observed zysary to associate a disease with all SNPs in the DNA gotic genotypes. The inference of diplotypes for a particsequence to understand the complete genetic control ular genotype is statistically a missing data problem that of the disease.
can be formulated by a finite mixture model (Wu and In this article, we present a novel statistical model for Casella 2005). determining specific DNA sequences that are associated Likelihood function: In this study, the complete data with the phenotypic variation of disease risk. This model are diplotype configurations at a given set of SNPs for is derived on the basis of multilocus haplotype analysis each genotype and for disease outcomes of subjects, using a finite number of tag SNPs. We derived a closedwhereas the observed data are the genotypes of these form solution for estimating the effects of haplotypes, SNPs and the disease outcomes. The missing data are at haplotype frequencies, allele frequencies, and the dethe connection from the genotypes to diplotypes. For grees of LD of various orders among tag SNPs underlyany given genotype, all possible diplotypes can be writing the disease. We performed simulation studies to test ten out. For example, genotype A of unknown haplotype frequencies given observed genotypes can be written as a multinomial form, i.e.,
are the probability density functions for subject i who
has two possible diplotypes, respectively, with the geno-ϩ n12/22 log(2p12p22) ϩ 2n22/11 log p21 ϩ n22/12 log(2p21p22) ϩ 2n22/22 log p22 .
] and the common residual variance of 2 . Note that subscript i is used to Assuming that diplotypes are associated with phenodescribe the genotypic means in the two density functypic variation in a disease, we formulate a likelihood tions above because these means are diplotype-(and for unknown population (⍀ p ) and quantitative genetic therefore subject-) dependent although there are only parameters (⍀ q ) given observed phenotypes (y) and SNP a total of 10 genotypic means for two SNPs. These means genotypes (G). Generally speaking, a given 2-SNP genoand variance are contained in vector
. Thus, such a Suppose there is a particular haplotype, A
, which is log-likelihood function can be formulated on the basis of different from the other three haplotypes, A
and
(where a bar means the alternative of that allele), in its effect on a complex disease. The phenotypic
means of the three genotypes that contain these two distinct groups of haplotypes are denoted as 1 for A
, and 3 for A
the basis of quantitative genetic theory, these three 's can be partitioned into the overall mean (), the addiwhere the mixture proportion, tive effect (a) due to the substitution of different haplotypes, and the dominant effect (d) due to the interaction between different haplotypes, i.e., 1 ϭ ϩ a, 2 ϭ ϩ
, and 3 ϭ Ϫ a. In Table 1 , the genotypic means are also given for different genotypes by assuming that represents the relative frequency of subject i whose haplotype
], and types.
The log-likelihood function described by Equation 2 can be expanded to include all possible SNP genotypes,
which is now expressed as
Note that for all the other genotypes, such probabilities
do not exist. In the M step, the probabilities calculated in the previ- 
iϭ1 y i n 11/11 , (11) given that these SNP genotypes are independent. It can be seen from the above likelihood function that, although most zygote genotypes contain a single compo-
nent (diplotype), the double heterozygote is the mixture of two possible diplotypes weighted by and 1
. Thus, an advanced statistical method should be implemented to obtain the MLEs of the underlying population and quantitative genetic parameters.
2 ϭ 1
An integrative EM algorithm: We derived a closedform solution for estimating the unknown parameters (14) with the EM algorithm (Dempster et al. 1977) . Haplotype frequencies can be expressed as a function of allelic where ṅ ϭ n 11/12 ϩ n 12/11 and n ϭ n 11/22 ϩ n 12/22 ϩ n 21/21 ϩ frequencies and LD. For a two-SNP haplotype, we have n 21/22 ϩ n 22/22 . Iterations including the E and M steps (1) the association between whereas the estimates of diplotype genotypic means two SNPs by testing their LD and (2) the difference of (and therefore the overall mean, haplotype additive, a given haplotype from the rest of the haplotypes in its and dominant effects) and residual variance are based effect on the disease outcome by testing the significance on the log-likelihood function of Equation 2. These two of haplotype additive and dominant effects. The LD different types of parameters can be estimated using an between two given SNPs can be tested using two alternaintegrative EM algorithm.
tive hypotheses: In the E step, the expected number ( i ) and probabilities (⌸ i ) of subject i of a . (6) model) using
erable computational load and, also, may not be necessary for the explanation of disease variation. Churchill and Doerge (1994) , which does not rely upon the distriSuppose two SNPs are segregating in a natural population at Hardy-Weinberg equilibrium. The allele frequenbution of the LR 2 , may be used to determine the critical threshold for determining the existence of a QTL.
cies and linkage disequilibrium between these two SNPs are given in Table 2 . We assume that one of the four R-SNP sequence model: The idea for sequencing a complex trait is described for a two-SNP model. It is possible haplotypes for the two SNPs is different from the rest of the haplotypes in their effects on the phenopossible that the two-SNP model is too simple to characterize genetic variants for quantitative variation. With type of a complex trait, which leads to three distinct groups of diplotypes. By assigning the genetic values for the analytical line for the two-SNP sequencing model, we can readily extend our model to include an arbitrary these two contrasting haplotypes under different gene action modes (Table 2) , we calculate the genotypic valnumber of SNPs whose sequences are associated with the phenotypic variation.
ues for all possible diplotypes and further simulate their phenotypic values on the basis of normal distribution. Consider R SNPs that form 3 R observable multilocus zygotic genotytpes, generally expressed as A
The residual variance is determined according to different heritability levels (0.1 vs. 0.4) expressed as the rela-
. These genotypes are collapsed from a total tive proportion of genetic variance to total observed of 2
basis of the genotypic values of all diplotypes and their A key issue for the multi-SNP sequencing model is how to distinguish among 2 rϪ1 different diplotypes for the frequencies. Table 2 describes the results of parameter estimation same genotype heterozygous at r loci. The relative frequencies of these diplotypes can be expressed in terms from our simulation using the proposed model. In general, all parameters (including population and quantitaof haplotype frequencies. The integrative EM algorithm can be employed to estimate the MLEs of haplotype tive genetic) can be reasonably estimated. As expected, the precision of population parameter estimation is a frequencies. Lou et al. (2003) provided a general formula for expressing haplotype frequencies in terms of function of sample size and does not rely on the H 2 value or the gene action mode. Large sample sizes always allele frequencies and linkage disequilibria of different orders. The MLEs of the latter can be obtained by solvlead to more precise estimation of allelic frequencies and linkage disequilibrium (Table 2) . ing a system of equations.
In the multi-SNP sequencing model, we face many The estimation precision of quantitative parameters is dependent on heritability level, sample size, and gene haplotypes and haplotype pairs. An Akaike information criterion-or Bayes information criterion-based model action mode. In almost all situations, the additive effects can be estimated better than the dominant effect. The selection strategy (Burnham and Andersson 1998) has been framed to determine the haplotype that is most estimation of additive and dominant effects responds differently to genetic action mode, depending on the distinct from the rest of the haplotypes in explaining quantitative variation. However, in practice, a simultadegree of dominance. For example, given the same heritability H 2 ϭ 0.1 and same sample size n ϭ 100, the neous analysis of too many SNPs will encounter consid- 
2 , and D are the allelic frequencies of alleles A
1 and A
2 at two SNPs and their linkage disequilibrium, respectively. is the overall mean, and a and d are the additive and dominant effects, respectively, by assuming that haplotype A
2 is different from the rest of haplotypes.
2 is the residual variance. LR 2 is the test statistics for testing the genetic effect of SNP haplotypes. "Power" is calculated as the percentages of all simulations that detect significant genetic effects. sampling error of the additive effect estimation is inthe dominance effect is reduced compared to that from the 2-SNP model. Second, the power to detect significreased by 121% from additive to dominant modes, but is stable from dominant to overdominant modes. These cant sequence variants and the estimation precision of different genetic parameters from the 3-SNP model can two percentage values are 1 and 42% for the sampling errors of the dominant effect estimation. It appears that be improved with increased heritability levels, increased sample sizes, and decreased gene interactions. the additive effect estimation is more sensitive than the dominant effect estimation to the changes of heritability A worked example: A real example from an obesity study is used to demonstrate the usefulness of our and sample size.
We analyze the power to detect a significant diplotype model. Numerous genes have been investigated as potential obesity-susceptibility genes (Mason et al. 1999 ; difference from our model under different combinations of H 2 value, sample size, and gene action mode Chagnon et al. 2003) . The ␤-2 adrenoceptor (BAR-2) is a major lipolytic receptor in human fat cells, whose (Table 2) . To do so, we first obtain empirical critical threshold values for declaring the significance of diplofunction was found to be determined by known polymorphisms in codons 16 and 27 (Green et al. 1995) . In type difference through simulations. The thresholds at the significance level ␣ ϭ 0.05 or 0.01 are estimated a genetic study of obesity involving 149 women by Large et al. (1997) , the Arg16Gly polymorphism at codon 16 as the 95th and 99th percentile for the simulated test statistics calculated from simulated data involving no was found to be associated with altered BAR-2 function with Gly16 carriers showing a fivefold increased agonist diplotype difference over 1000 LR 2 values. It is clear that increased H 2 levels and increased sample sizes can insensitivity. The Gln27Glu polymorphism at codon 27 is markedly associated with obesity traits. The homozygotes crease the power to detect diplotype differences. When H 2 ϭ 0.4 or n ϭ 400, such power is 100% (Table 2) . for Glu27 display an average fat mass excess of 20 kg and 50% larger fat cells than controls. Although the Arg16Gly An additional simulation study was performed to investigate the statistical behavior of the multi-SNP sepolymorphism is not significantly associated with obesity and the Gln27Glu polymorphism is not significantly quence model. The results from the 3-SNP sequence model are summarized in Table 3 . First, all genetic associated with the BAR-2 function, genetic variability in these two sites of the human BAR-2 gene could be parameters can be reasonably estimated from the 3-SNP sequence model, although the estimation precision of of major importance for obesity, energy expenditure, See Table 2 for explanations of parameters.
and lipolytic BAR-2 function in adipose tissue, at least for allele G at codon 16 and 0.38 for allele G at codon 27, respectively, suggesting that both of them have fairly in women (Large et al. 1997) .
To determine whether sequence variants at these two high heterozygosity. Our model is based on the assumption that one haplopolymorphisms of BAR-2 are associated with obesity phenotypes, we investigated a group of 155 women of type is different from the rest of the haplotypes. In a practical situation, as in our example used here, the ages 32 to 86 years old with a large variation in body fat mass. Each of these patients was determined for her issue of how these haplotypes differ in their effects is not known. By assuming that any one haplotype is different genotypes at codon 16 with two alleles, Arg16 (A) and Gly16 (G), and at codon 27 with two alleles, Gln27 (C) from the rest of the haplotypes, we can find a bestdifference pattern that is based on the estimates of the and Glu27 (G), within the BAR-2 gene and measured for body mass index (BMI). These two SNPs form four LR 2 's using Equation 16. When haplotype GG, GC, AG, or AC is assumed to differ in BMI from the other haplohaplotypes designated as AC, AG, GC, and GG, which lead to nine genotypes, AA/CC, AA/CG, AA/GG, AG/ types, the LR 2 values were estimated as 10.35, 3.11, 1.52, and 2.32, respectively. Obviously, haplotype GG is con-CC, AG/CG, AG/GG, GG/CC, GG/CG, and GG/GG, and the 10 corresponding diplotypes, [ (Table 4) . These two well beyond the critical threshold value at the significance level of 1% (6.07) estimated from 1000 simulation SNPs are highly associated with each other, whose LD is estimated as 0.1261. The allele frequencies are ‫16.0ف‬
replicates. Haplotype GG displays large additive and and, therefore, physiological function. As opposed to The difference between haplotype GG and the rest of the traditional "indirect" approach, our model presents the haplotypes can explain 6.3% of the observed variaa "direct" approach. At present, the utility of the direct tion in BMI. We estimate the standard errors of the approach is limited to sequencing the functional parts MLEs of the population and quantitative genetic paramof candidate genes with known biochemical or physioeters on the basis of Louis's (1982) observed informalogical function. With the release of HapMap, our model tion matrix, suggesting that all MLEs have reasonable will make the direct approach more useful and more estimation precision although the estimates of quantitaefficient in searching for causal variants throughout the tive genetic parameters are not as precise as those of whole genome. Our model is also different from tradipopulation genetic parameters due to a small sample tional association studies (e.g., Zaykin et al. 2002) whose size used (see the simulation result in Tables 2 and 3). aims are the significance test for the association between haplotypes and phenotypes (mostly discrete traits) rather than the precise estimation of haplotype effects. Second, DISCUSSION our model is statistically simple and computationally fast. The most difficult part for the estimation from The elucidation of the entire human genome using SNPs will make it possible to develop a haplotype map our model is to construct diplotype configurations for heterozygous genotypes at two or more SNPs. The estiof the human genome. Although such a HapMap has been recently available due to international collaboramation of population genetic parameters is based on a multinomial-likelihood function of the observed genotions (International HapMap Consortium 2003) , there is a serious lack of powerful statistical tools for type data, whereas the estimation of quantitative genetic parameters is based on a mixture-based likelihood funcspecific utility of this expensive HapMap to detect genes and genetic variations that affect health and disease.
tion including different diplotypes. These two likelihood functions can be easily integrated to a unified estimation Such a statistical model has been developed and presented in this article. The idea behind our statistical framework implemented with the EM algorithm. Finally, our model is flexible to different genetic and modeling is that differences between SNP-constructed haplotypes may be associated with differing susceptibilexperimental settings. The results from a simulation study indicate that the association between DNA sequence ity to disease (International HapMap Consortium 2003) .
and phenotype can be well detected when the trait has a modest heritability level (0.1) or a modest sample size SNPs reside at sites in the DNA sequence where indi-
